Auckland City Hospital ( Site 1901)

Auckland 1023

0 studies enrolling now · 2 studies all time

What they study most

Bladder Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Cancer

Studies at this site

• Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65). — Running, not enrolling
• A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005) — Running, not enrolling